Autologous HSCT in systemic sclerosis: A step forward

The Lancet

Volumn 378, Issue 9790, 2011, Pages 460-462

  Farge, Dominique ^a   Gluckman, Eliane ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; THYMOCYTE ANTIBODY;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; DISEASE SEVERITY; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; NOTE; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 80051472129     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61100-8     Document Type: Note

References (14)

1. RT Domsic, T Rodriguez-Reyna, M Lucas, N Fertig, TA Medsger Jr Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma Ann Rheum Dis 70 2011 104 109
2. D Farge, J Passweg, JM van Laar et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry Ann Rheum Dis 63 2004 974 981 (Pubitemid 38961924)
3. Y Oyama, WG Barr, L Statkute et al. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis Bone Marrow Transplant 40 2007 549 555 (Pubitemid 47382125)
4. PA McSweeney, RA Nash, KM Sullivan et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes Blood 100 2002 1602 1610 (Pubitemid 34925135)
5. RA Nash, PA McSweeney, LJ Crofford et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study Blood 110 2007 1388 1396 (Pubitemid 47281441)
6. D Farge, M Labopin, A Tyndall et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases Haematologica 95 2010 284 292
7. F Verrecchia, J Laboureau, O Verola et al. Skin involvement in scleroderma - where histological and clinical scores meet Rheumatology (Oxford) 46 2007 833 841 (Pubitemid 47061718)
8. D Launay, Z Marjanovic, C de Bazelaire et al. Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring J Rheumatol 36 2009 1460 1463
9. RK Burt, SJ Shah, K Dill et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial Lancet 2011 10.1016/S0140-6736(11)60982-3 published online July 20.
10. S Abrahamsson, PA Muraro Immune re-education following autologous hematopoietic stem cell transplantation Autoimmunity 41 2008 577 584
11. FG Miller, S Joffe Equipoise and the dilemma of randomized clinical trials N Engl J Med 364 2011 476 480
12. C Nannini, CP West, PJ Erwin, EL Matteson Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies Arthritis Res Ther 10 2008 R124
13. D Farge, C Henegar, M Carmagnat et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis Arthritis Rheum 52 2005 1555 1563 (Pubitemid 40663947)
14. Snowden J, Saccardi R, Allez M, et al, on behalf of the EBMT Autoimmune Disease (ADWP) and Paediatric Diseases (PDWP) Working Parties. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (in press).